SurModics Inc (SRDX)

[aslan2772]

Thanks Dew, we'll have to examine the 7 year randomized study comparing drugs to drugs plus stents when the results are in at ACC in March. However, since stents have already failed to shown a prolonging of life, I would not expect to see any survival benefit of stents plus drugs over drugs alone. I wonder if freedom from angina or other lifestyle factors will be a metric in that study?

I think the key challenge for stents (BMS or DES) is to provide symptomatic relief without unduely increasing the overall risk of adverse events. That many patients are willing to undergo CABG tells us, I think, something about the severity of the pain associated with this disease.